Bladder Cancer Trial, Recruiting NCT06719232 Sponsor: Jahn Ferenc South Pest Teaching Hospital Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06719232
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 80 years old (both men and women)
  • People whose doctor has decided they need a treatment where medicine is put directly into the bladder for one of the following reasons: a painful bladder condition (interstitial cystitis/bladder pain syndrome), frequent bladder infections, a type of early bladder cancer that hasn't spread into the bladder muscle, bladder problems caused by previous radiation treatment, or bladder problems caused by previous chemotherapy
  • People who have had a urine test (to check for infection) come back clear within the last two weeks
  • People who agree to take part in the study and sign a consent form

Who may not be able to join:

  • People who have had a urinary tract infection in the past month, or who currently have an active infection
  • People who have been diagnosed with a bleeding disorder or who regularly have visible blood in their urine
  • People who have more than 100 ml of urine left in their bladder after going to the toilet (confirm with trial site)
  • People who have a mental health condition that would make it difficult for them to reliably take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Tenke, Professor of Urology, South Pest Teaching Hospital

Phone: +3612896200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jahn Ferenc South Pest Teaching Hospital
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Patient Discomfort During Catheter-Free Intravesical Instillation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov